AHSCT is a recognized as a safe and highly effective immune reconstitution therapy for people with multiple sclerosis (MS), particularly patients with relapsing-remitting MS (RRMS). The efficacy of AHSCT therapy has been demonstrated in several studies resulting in extended periods of disease remission, improvement in disability, and the absence of new MRI lesions. While AHSCT is not a cure to MS itself, proper functioning of the immune system post-chemotherapy can prevent myelin deterioration, further damage to myelin and restore proper electrical flow within the nervous system.
Studies and clinical trials have shown that AHSCT is a safe and effective therapeutic approach to reduce or eliminate a series of relapses, cease further disease progression, and lessen effects of the disorder. The reasons for this therapy’s success are its lower toxicity and ability to replace the immune system, which improves disability after treatment.
Takes about 3-4 days. A detailed examination always precedes the final decision.
Read MoreAbout 5-6 days, depending on the results of stem cells collection
Read MoreAfter finishing chemotherapy we provide stem cell reinfusion, it takes less than 3 hours
Read MoreIsolation period during 14 days to rebuild immune system in the aseptic unit of the hospital.
Read MoreIt may take a few months for your immune system to recover and start a NEW LIFE
Read MoreThank you for your interest in our work at ADIA Med. We are committed to advancing MS research and improving patient outcomes. If you have any questions, need more information about our studies, or are interested in investing, our team is here to assist you. Please reach out using the contact form or through the provided contact details, and we will respond as quickly as possible. We look forward to connecting with you and exploring how we can work together to make a meaningful impact in the field of healthcare.